01 2Anonima Materie Sintetiche and Affini (AMSA) Spa
02 1Arch Pharmalabs Limited
03 1Aurobindo Pharma Limited
04 2Bidachem S.p.a.
05 1Cipla Ltd.
06 1Derivados Quimicos SAU
07 1Ipca Laboratories Limited
08 1Kalchem International inc
09 1LETCO MEDICAL, LLC
10 1Medisca Inc.
11 1Professional Compounding Centers of America dba PCCA
12 1Quimica Sintetica S.A.
13 1Shandong Xinhua Pharmaceutical Company Limited
14 1Spectrum Laboratory Products, Inc.
15 1Swati Spentose Private Limited
16 1Unichem Laboratories Limited, India
17 1Xenex Laboratories Inc
18 1Zydus Lifesciences Limited
01 5MELOXICAM
02 13Meloxicam
03 2meloxicam
01 1Canada
02 1China
03 7India
04 4Italy
05 2Spain
06 4U.S.A
07 1United Kingdom
NDC Package Code : 17373-1158
Start Marketing Date : 2017-01-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 17373-1157
Start Marketing Date : 2017-01-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 22365-116
Start Marketing Date : 2010-01-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51869-0007
Start Marketing Date : 2000-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51869-0008
Start Marketing Date : 2000-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-2746
Start Marketing Date : 2014-05-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0032
Start Marketing Date : 2014-03-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 53069-0790
Start Marketing Date : 2005-11-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-4402
Start Marketing Date : 2015-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52119-003
Start Marketing Date : 2019-02-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Meloxicam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Meloxicam, including repackagers and relabelers. The FDA regulates Meloxicam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Meloxicam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Meloxicam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Meloxicam supplier is an individual or a company that provides Meloxicam active pharmaceutical ingredient (API) or Meloxicam finished formulations upon request. The Meloxicam suppliers may include Meloxicam API manufacturers, exporters, distributors and traders.
click here to find a list of Meloxicam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Meloxicam as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Meloxicam API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Meloxicam as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Meloxicam and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Meloxicam NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Meloxicam suppliers with NDC on PharmaCompass.
We have 18 companies offering Meloxicam
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
